Managing IP is rounding up important intellectual property decisions coming out of Canadian courts last year. In two patent cases, the Court of Appeal suggested a new legal test for determining the relevance of a non-infringing alternative and ruled that a generic cannot make a claim for innovator profits under the doctrine of unfair enrichment
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio